Alirinetide exhibits potent anti-inflammatory properties, effectively targeting specific receptors involved in allergic responses. This innovative drug has demonstrated promising results in alleviating symptoms and improving the overall quality of life for patients suffering from conditions such as asthma and allergic rhinitis.
CAT No: R2014
CAS No: 725715-18-4
Synonyms/Alias: Alirinetide;725715-18-4;6BK9OEG8CC;GM-608;GM-602;GM-604;GM-606;GM-6;L-Arginine, L-phenylalanyl-L-seryl-L-arginyl-L-tyrosyl-L-alanyl-;UNII-6BK9OEG8CC;ALIRINETIDE [INN];ALIRINETIDE [WHO-DD];L-phenylalanyl-L-seryl-L-arginyl-L-tyrosyl-L-alanyl-L-arginine;GM-603;GM-605;GM-607;GM-609;(2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-(((2S)-2-Amino-3-phenyl-propanoyl)amino)-3-hydroxy-propanoyl)amino)-5-guanidino-pentanoyl)amino)-3-(4-hydroxyphenyl)propanoyl)amino)propanoyl)amino)-5-guanidino-pentanoic acid;(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid;alirinetida;alirinetidum;GM602;GM603;GM605;GM607;GM608;GM609;GM 604;AKOS040751941;DA-70695;HY-107130;CS-0027391;
Chemical Name: (2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]-5-(diaminomethylideneamino)pentanoic acid
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C36H54N12O9 |
M.W/Mr. | 798.9 |
Sequence | One Letter Code:FSRYAR Three Letter Code:H-Phe-Ser-Arg-Tyr-Ala-Arg-OH |
InChI | InChI=1S/C36H54N12O9/c1-20(29(51)46-26(34(56)57)10-6-16-43-36(40)41)44-32(54)27(18-22-11-13-23(50)14-12-22)47-31(53)25(9-5-15-42-35(38)39)45-33(55)28(19-49)48-30(52)24(37)17-21-7-3-2-4-8-21/h2-4,7-8,11-14,20,24-28,49-50H,5-6,9-10,15-19,37H2,1H3,(H,44,54)(H,45,55)(H,46,51)(H,47,53)(H,48,52)(H,56,57)(H4,38,39,42)(H4,40,41,43)/t20-,24-,25-,26-,27-,28-/m0/s1 |
InChI Key | WVPOPWDCSFQEBI-HJJAOGADSA-N |
Canonical SMILES | CC(C(=O)NC(CCCN=C(N)N)C(=O)O)NC(=O)C(CC1=CC=C(C=C1)O)NC(=O)C(CCCN=C(N)N)NC(=O)C(CO)NC(=O)C(CC2=CC=CC=C2)N |
Isomeric SMILES | C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC2=CC=CC=C2)N |
1. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
3. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry
5. High fat diet and GLP-1 drugs induce pancreatic injury in mice
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.